Transcode Therapeutics Stock

Transcode Therapeutics Financial Debt Ratio

Financial Debt Ratio of Transcode Therapeutics (RNAZ) as of Aug 22, 2026.

Financial Debt Ratio

0.00

Last updated:

Financial Debt Ratio of Transcode Therapeutics is 2026 0.00 . Financial Debt Ratio of Transcode Therapeutics was 2025 0.00 . It decreases by % lower compared to the previous year.

The Transcode Therapeutics Financial Debt Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Debt Ratio
Date
Financial Debt Ratio
Jan 1, 2018
202.79 USD
Jan 1, 2019
454.90 USD
Jan 1, 2020
197.82 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
The Transcode Therapeutics Financial Debt Ratio history
YEARFinancial Debt RatioYoY
0.00—
0.00—
0.00—
0.00-100.00%
197.82 %-56.51%
454.90 %+124.32%
202.79 %—
Access this data via the Eulerpool API
Get Free API Key

Transcode Therapeutics Stock analysis

What does Transcode Therapeutics do? Transcode Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transcode Therapeutics stock

On Eulerpool you can find the complete historical development of Financial Debt Ratio Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's Transcode Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Transcode Therapeutics

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Transcode Therapeutics